Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line

Lipid nanocapsules (LNCs) represent a stable, biocompatible and worthwhile drug delivery system, demonstrating significant potential as gene/drug delivery platforms for cancer therapy. Imatinib, a potent tyrosine kinase inhibitor, has revolutionized the therapy of malignancies resulting from abnorma...

Descripción completa

Detalles Bibliográficos
Autores principales: Molaahmadi, Mohammad Reza, Varshosaz, Jaleh, Taymouri, Somayeh, Akbari, Vajihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059069/
https://www.ncbi.nlm.nih.gov/pubmed/32184838
http://dx.doi.org/10.22037/ijpr.2019.1100870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059069/
https://www.ncbi.nlm.nih.gov/pubmed/32184838
http://dx.doi.org/10.22037/ijpr.2019.1100870

Ejemplares similares